David E. Weinstein
Chief Executive Officer at David Weinstein Consulting, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Altman | M | - |
Rivertown Therapeutics, Inc.
 Rivertown Therapeutics, Inc. BiotechnologyHealth Technology Rivertown Therapeutics, Inc. develops novel and topically applied prescription products. The company was founded by Michael Altman and David Weinstein in 2015 and is headquartered in Dobbs Ferry, NY. | 9 years |
| Augustine Lawlor | M | 67 | 4 years | |
| Ellen Baron | M | 71 | 4 years | |
| Bradley Margus | M | 63 |
National Institute of Neurological Disorders & Stroke
| - |
| Deborah G. Hirtz | F | - |
National Institute of Neurological Disorders & Stroke
| - |
| Allison Hulme | M | 61 |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | 11 years |
| Story C. Landis | M | - |
National Institute of Neurological Disorders & Stroke
| - |
| Cindy Parseghian | F | - |
National Institute of Neurological Disorders & Stroke
| - |
| Steven Weinstock | M | - |
Rivertown Therapeutics, Inc.
Rivertown Therapeutics, Inc. BiotechnologyHealth Technology Rivertown Therapeutics, Inc. develops novel and topically applied prescription products. The company was founded by Michael Altman and David Weinstein in 2015 and is headquartered in Dobbs Ferry, NY. | - |
| Lorna Role | F | - |
National Institute of Neurological Disorders & Stroke
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Evgeny Zaytsev | M | 56 |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | 7 years |
| Eylon Penchas | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 9 | 75.00% |
| Israel | 3 | 25.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David E. Weinstein
- Personal Network
